|
業務類別
|
-- |
|
業務概覽
|
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consultingservices for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions. |
| 公司地址
| 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131 |
| 電話號碼
| +86 2150461111 |
| 傳真號碼
| +86 2150461000 |
| 公司網頁
| https://www.wuxiapptec.com |
| 員工數量
| 33834 |
| Mr. Zhaohui Zhang |
Director, Vice President and Chief Operating Officer, China |
-- |
01/04/2026 |
| Dr. Steve Qing Yang, PhD |
Director and Co-Chief Executive Officer |
-- |
01/04/2026 |
| Dr. Ge Li |
Chairman of the Board, Chief Executive Officer and President |
-- |
01/04/2026 |
| Dr. Minzhang Chen |
Director and Co-Chief Executive Officer |
-- |
01/04/2026 |
|
|
| Ms. Lu-Wong Christine Shaohua |
Independent Director |
01/04/2026 |
| Mr. Xuesong Jeff Leng |
Independent Director |
01/04/2026 |
| Mr. Zhaohui Zhang |
Director, Vice President and Chief Operating Officer, China |
01/04/2026 |
| Dr. Zhang Xin |
Independent Director |
01/04/2026 |
| Dr. Steve Qing Yang, PhD |
Director and Co-Chief Executive Officer |
01/04/2026 |
| Dr. Yibing Wu, PhD |
Director |
01/04/2026 |
| Dr. Ge Li |
Chairman of the Board, Chief Executive Officer and President |
01/04/2026 |
| Mr. Xiaomeng Tong |
Director |
01/04/2026 |
| Dr. Minzhang Chen |
Director and Co-Chief Executive Officer |
01/04/2026 |
| Ms. Zhiling Zhan |
Independent Director |
01/04/2026 |
| Dr. Yu Wei |
Independent Director |
01/04/2026 |
|
|
|
|
